Product image of Columvi (Glofitamab) supplied by GNH India

Columvi

Active Ingredient:
Glofitamab
Origin:
EU

Columvi (Glofitamab)

Columvi (Glofitamab) is an intravenous medication used for targeted therapy. Learn about its uses, effects, and precautions in this comprehensive guide.

Manufacturer / TM Owner

Roche Registration Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Columvi (Glofitamab) is primarily used in the treatment of certain types of cancer. It works by targeting specific proteins on cancer cells to help the immune system recognize and attack them. This medication is often used in cases where other treatments have not been effective. Patients and healthcare providers may explore 'what is Columvi used for' to understand its role in cancer therapy.

Side Effects

  • Columvi (Glofitamab) may cause various effects, including infusion-related reactions such as fever, chills, and fatigue. Other common effects may include nausea, vomiting, and changes in blood cell counts. It is important to monitor for any unusual symptoms and report them to a healthcare provider.

Precautions & Warnings

  • Columvi (Glofitamab) should be handled with care and administered under the supervision of a healthcare professional. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment. Regular blood tests may be required to monitor for potential side effects.

Avoid Interactions

  • Columvi (Glofitamab) may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the effectiveness of Columvi.

Frequently Asked Questions

Columvi (Glofitamab) is used for the treatment of certain types of cancer, targeting specific proteins on cancer cells.

Columvi is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common effects of Columvi may include infusion-related reactions, fatigue, nausea, and changes in blood cell counts.

Patients should inform their healthcare provider about any allergies or medical conditions before starting Columvi treatment.

Columvi may interact with other medications, especially those that affect the immune system. Always consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glofitamab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT